J Biomed Nanotechnol. 2014 May;10(5):871-6. doi: 10.1166/jbn.2014.1792.
The biotin-Streptavidin (STREP) technique for attachment of monoclonal antibodies (mAbs) (or other ligand types) on liposome surface offers high attachment yield, however it is time consuming and expensive due to the number of steps used and the consumption of large quantities of STREP. Herein, a simplified, fast and economic technique, by incubating pre-mixed biotin-mAb/STREP with biotin-liposomes, at a 3:1:1 biotin-mAb/STREP/biotin-LIP ratio (mol/mol/mol) was evaluated. The physichochemical properties, final mAb attachment yield and targeting potential of liposomes decorated with an anti-transferrin receptor mAb (TfR-mAb), prepared by the simple method (SM) and the conventional method (CM), were compared. The vesicle uptake by hCMEC/D3 cells (known to overexpress TfR) were considered as a measure of liposome targeting capability. Results show that both targeted liposome types (SM and CM) have small size (mean diameters around 150 nm), low poly-dispersity (approx. 0.20) and similar mAb attachment yield (between 64-88%). However, the uptake of the SM-liposomes is slightly lower compared to CM-LIP (24-30% decrease), suggesting that the modulated conformation of mAbs on the liposome surface (triplets attached to one single STREP molecule) results in decreased targeting capability. Nevertheless, the simpler and faster one-step preparation procedure which has very high lipid recovery (> 95%) compared to the CM (50-60%) and 15-30 times lower consumption of STREP, may be a good alternative for initial screening of various mAbs as ligands for targeted liposomal or other nanotechnologies, during pre-clinical development.
生物素-链霉亲和素(STREP)技术用于将单克隆抗体(mAb)(或其他配体类型)附着在脂质体表面上,具有很高的附着产率,但由于使用的步骤数量和大量 STREP 的消耗,该技术既耗时又昂贵。在此,评估了一种简化、快速且经济的技术,即将预先混合的生物素-mAb/STREP 与生物素脂质体孵育,以 3:1:1 的生物素-mAb/STREP/生物素-LIP 比(摩尔/摩尔/摩尔)进行孵育。通过简单方法(SM)和常规方法(CM)制备的,用抗转铁蛋白受体 mAb(TfR-mAb)修饰的脂质体的物理化学性质、最终 mAb 附着产率和靶向潜力进行了比较。用 hCMEC/D3 细胞(已知过表达 TfR)摄取囊泡作为衡量脂质体靶向能力的指标。结果表明,两种靶向脂质体类型(SM 和 CM)的粒径均较小(平均直径约为 150nm),多分散性低(约 0.20),mAb 附着产率相似(64-88%)。然而,与 CM-LIP 相比,SM-脂质体的摄取量略低(降低 24-30%),这表明 mAb 在脂质体表面上的调制构象(三个附着在一个单独的 STREP 分子上)导致靶向能力降低。然而,与 CM(50-60%)相比,这种更简单、更快的一步制备方法具有非常高的脂质回收率(>95%),并且 STREP 的消耗量低 15-30 倍,可能是临床前开发过程中作为靶向脂质体或其他纳米技术的配体的各种 mAb 的初始筛选的良好选择。